Does TEPROTUMUMAB-TRBW Cause Type v hyperlipidaemia? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Type v hyperlipidaemia have been filed in association with TEPROTUMUMAB-TRBW. This represents 0.2% of all adverse event reports for TEPROTUMUMAB-TRBW.
12
Reports of Type v hyperlipidaemia with TEPROTUMUMAB-TRBW
0.2%
of all TEPROTUMUMAB-TRBW reports
0
Deaths
2
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From TEPROTUMUMAB-TRBW?
Of the 12 reports, 2 (16.7%) required hospitalization.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPROTUMUMAB-TRBW. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TEPROTUMUMAB-TRBW Cause?
Muscle spasms (998)
Fatigue (704)
Tinnitus (524)
Headache (443)
Hypoacusis (430)
Diarrhoea (408)
Nausea (407)
Blood glucose increased (401)
Alopecia (390)
Pain (344)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which TEPROTUMUMAB-TRBW Alternatives Have Lower Type v hyperlipidaemia Risk?
TEPROTUMUMAB-TRBW vs TERAZOSIN
TEPROTUMUMAB-TRBW vs TERAZOSIN\TERAZOSIN
TEPROTUMUMAB-TRBW vs TERBINAFINE
TEPROTUMUMAB-TRBW vs TERBINAFINE\TERBINAFINE
TEPROTUMUMAB-TRBW vs TERBUTALINE